CheckMate 214 Results Positive Overall

CheckMate 214 Results Positive Overall

Cancer-News

2 years
869 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Scott S. Tykodi, MD reveals the results of the Checkmate - 214 trial with combined immunotherapy nivolumab plus ipilimumab and explains the positive results on objective response rate and prolonged progression-free survival compared to sunitinib in intermediate- and poor-risk patients with previously untreated advanced or metastatic renal cell carcinoma.
Up Next Autoplay